Literature DB >> 7512972

The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C.

K Matsumoto1, Y Saga, T Ikemura, T Sakakura, R Chiquet-Ehrismann.   

Abstract

We have isolated a cDNA encoding mouse tenascin-X (TN-X), a new member of the family of tenascin genes. The TN-X gene lies in the major histocompatibility complex (MHC) class III region, as it is the case for its human counterpart. On Northern blots we detected a TN-X mRNA of approximately 13 kb in most tissues analyzed, whereas in various mouse cell lines mRNAs of approximately 11 and 13 kb were detected, suggesting the possibility of alternative splicing of TN-X transcripts. We raised antibodies against mouse TN-X fragments expressed in bacteria and used these antibodies to identify the TN-X protein in heart cell extracts and in the conditioned medium of a renal carcinoma cell line. The subunit molecular size of TN-X is approximately 500 kD, suggesting that the protein may contain up to 40 fibronectin type III repeats, making it the largest tenascin family member known yet. TN-X in conditioned medium, as well as the purified protein bind to heparin, but no binding to tenascin-C (TN-C), fibronectin, laminin or collagens could be detected. Thus the heparin-binding activity may be a common feature of the tenascins. The TN-X mRNA as well as the protein are predominantly expressed in heart and skeletal muscle, but the mRNA is found in most tissues at a low level. Immunostaining showed the protein to be associated with the extracellular matrix of the muscle tissues and with blood vessels in all of the tissues analyzed. Although the TN-X gene lies in the MHC class III locus, it is not expressed in the lymphoid organs analyzed, except for the staining around blood vessels. In skin and tissues of the digestive tract often a reciprocal distribution of TN-X and TN-C was observed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512972      PMCID: PMC2120029          DOI: 10.1083/jcb.125.2.483

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  48 in total

Review 1.  Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin.

Authors:  E H Sage; P Bornstein
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

2.  Binding of hexabrachions to heparin and DNA.

Authors:  L S Marton; J R Gulcher; K Stefansson
Journal:  J Biol Chem       Date:  1989-08-05       Impact factor: 5.157

3.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

Review 4.  What distinguishes tenascin from fibronectin?

Authors:  R Chiquet-Ehrismann
Journal:  FASEB J       Date:  1990-06       Impact factor: 5.191

Review 5.  Tenascin and other adhesion-modulating proteins in cancer.

Authors:  R Chiquet-Ehrismann
Journal:  Semin Cancer Biol       Date:  1993-10       Impact factor: 15.707

Review 6.  Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions.

Authors:  H P Erickson
Journal:  Curr Opin Cell Biol       Date:  1993-10       Impact factor: 8.382

7.  HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation.

Authors:  P C White; M I New; B Dupont
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

Review 8.  Tenascin-C in peripheral nerve morphogenesis.

Authors:  M Chiquet; B Wehrle-Haller
Journal:  Perspect Dev Neurobiol       Date:  1994

9.  The extracellular matrix of lip wounds in fetal, neonatal and adult mice.

Authors:  D J Whitby; M W Ferguson
Journal:  Development       Date:  1991-06       Impact factor: 6.868

10.  Tenascin during gut development: appearance in the mesenchyme, shift in molecular forms, and dependence on epithelial-mesenchymal interactions.

Authors:  E Aufderheide; P Ekblom
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

View more
  28 in total

Review 1.  The Ehlers-Danlos syndrome: on beyond collagens.

Authors:  J R Mao; J Bristow
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 2.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

Review 3.  Extracellular matrix of the central nervous system: from neglect to challenge.

Authors:  Dieter R Zimmermann; María T Dours-Zimmermann
Journal:  Histochem Cell Biol       Date:  2008-08-12       Impact factor: 4.304

4.  Changes in the chondrocyte and extracellular matrix proteome during post-natal mouse cartilage development.

Authors:  Richard Wilson; Emma L Norris; Bent Brachvogel; Constanza Angelucci; Snezana Zivkovic; Lavinia Gordon; Bianca C Bernardo; Jacek Stermann; Kiyotoshi Sekiguchi; Jeffrey J Gorman; John F Bateman
Journal:  Mol Cell Proteomics       Date:  2011-10-11       Impact factor: 5.911

Review 5.  Matricellular proteins in the trabecular meshwork: review and update.

Authors:  Ayan Chatterjee; Guadalupe Villarreal; Douglas J Rhee
Journal:  J Ocul Pharmacol Ther       Date:  2014-06-05       Impact factor: 2.671

6.  Titin-based stiffening of muscle fibers in Ehlers-Danlos Syndrome.

Authors:  Coen A C Ottenheijm; Nicol C Voermans; Bryan D Hudson; Thomas Irving; Ger J M Stienen; Baziel G van Engelen; Henk Granzier
Journal:  J Appl Physiol (1985)       Date:  2012-01-05

7.  Immunolocalization of tenascin-C in human type II fiber atrophy.

Authors:  B G Schoser; A Faissner; H H Goebel
Journal:  J Mol Neurosci       Date:  1999 Aug-Oct       Impact factor: 3.444

Review 8.  Tenascins, a growing family of extracellular matrix proteins.

Authors:  R Chiquet-Ehrismann
Journal:  Experientia       Date:  1995-09-29

9.  The phenotypic spectrum of contiguous deletion of CYP21A2 and tenascin XB: quadricuspid aortic valve and other midline defects.

Authors:  Wuyan Chen; Mimi S Kim; Sujata Shanbhag; Andrew Arai; Carol VanRyzin; Nazli B McDonnell; Deborah P Merke
Journal:  Am J Med Genet A       Date:  2009-12       Impact factor: 2.802

10.  Recombination in the class III region of the mouse major histocompatibility complex.

Authors:  M Yoshino; T Sagai; K F Lindahl; Y Toyoda; Y Shirayoshi; K Matsumoto; K Sugaya; T Ikemura; K Moriwaki; T Shiroishi
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.